The Division of Pharmacotherapy and Experimental Therapeutics, in conjunction with UNC and Duke hospitals, takes therapeutic agents to their intended subjects: humans. Division researchers focus on three phases of clinical assessment and evaluation of drug targets: safety, efficacy, and the impact on specialized populations. Faculty help determine dosing, toxicity, and drug interactions for a number of emerging therapeutic drugs.
The Division of Pharmacotherapy and Experimental Therapeutics has the unique responsibility within the
School of Pharmacy to provide classroom and clinical instruction for pharmacy students in the practice of pharmacy and to train graduate and postgraduate pharmacists in the principles of clinical research. The faculty of the Division of Pharmacotherapy and Experimental Therapeutics are clinical practitioners who bring insights from the patient-care setting to their teaching, translational research, and professional service activities.
Postgraduate research opportunities in the division are provided through two-year fellowship programs. Fellowships in an academic setting or in the pharmaceutical industry emphasize research skills and offer specialization in areas such as drug development, pharmacokinetics and pharmacoeconomics.
The division provides the leadership for professional education and practice for the School as well as the state. The division has two core values: pharmaceutical care and experimental therapeutics.
For more information, please click on the links below:
| |